94
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Use of mobile technology in preventing leprosy impairments

ORCID Icon &
Pages 602-604 | Received 21 Apr 2020, Accepted 29 Jul 2020, Published online: 07 Aug 2020
 

Abstract

Aim

Rapid development in telecommunication sector across the globe has revolutionised communication networks even in rural areas. At a tertiary leprosy referral hospital in Tamil Nadu, India, leprosy treatment was started for a male patient presenting with clinical signs and symptoms suggestive of leprosy. Since the patient was from a remote area, but needed close and continuous monitoring, he was provided with a mobile phone and a 12 h toll free number.

Methods

The patient was able to provide detailed regular information of his health status to the health worker, through the toll free number from the mobile phone given to him. The patient defaulted during his treatment. Within a few days of his defaulting, a follow up call was made and the patient revealed that he did not have enough financial resources to visit the hospital and continue his treatment.

Results

The patient was visited by a health worker and was reassured. Arrangements were made by the hospital to reimburse his travel costs.

Conclusion

Utilising the advancements in technology would help in solving some of the key unanswered issues existing in leprosy. The use of technology helps facilitate and complement the work of health workers in reaching out to patients living in remote areas.

    IMPLICATIONS FOR REHABILITATION

  • The use of M (mobile) - health in treatment compliance and adherence

  • The use of M-health in the prevention and management of impairments in leprosy

  • Effective monitoring and follow up of patients with impairments through mobile

Acknowledgement

The authors would like to the acknowledge Dr. Jerry Joshua, Director, SIHRLC Karigiri for his valuable inputs and suggestions.

Disclosure statement

The authors of this study have no declaration interest.

Additional information

Funding

The authors would like to acknowledge the Leprosy Research Initiative (www.leprosyresearch.org) for funding this project through the grant LRI. 705.17.41/LRI/DEF.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.